Health Trials

30 Days and 90 Days Heart Failure Re-Admission at Komfo Anokye Teaching Hospital

ConditionHeart Failure
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorKomfo Anokye Teaching Hospital

About this trial

In Ghana, about 88.3 per cent of cardiac admissions are due to Heart failure, making it the leading cause of admission due to heart conditions. Despite improved knowledge on heart failure and an increasing array of evidence-based guideline treatment options, there is still a significant readmission rate worldwide. This may be due to the underutilization of these evidence-based therapies or a lack of proper follow-up on these patients. Recurrent hospital admission is an independent predictor of death in heart failure. Strategies aimed at providing increased support at discharge and effective follow-up may be associated with lower readmission risk. This study aims to assess the effect of extensive post-discharge counselling and effective phone-based follow-up on the 30-day and 90-day heart failure readmission rate at a tertiary hospital in Ghana. This is a single-centre, pilot randomised controlled trial of heart failure patients admitted to the Komfo Anokye Teaching Hospital

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

· Adults Aged 18 years and above

Diagnosed with heart failure

NYHA Class II-IV

Informed consent

Disqualifiers

· NHYA class I

Patients who do not have access to a mobile phone

Trial design

Design model

Parallel

Treatments tested in this trial

  • Extensive post discharge counselling and phone-based follow up

    Other intervention

    Counselling by their attending physicians plus Extensive post-discharge counselling from a study doctor/pharmacist/a trained nurse and telephone follow-ups in addition to their normal outpatient reviews. The telephone follow-ups will be weekly for the first 30 days and then 4 weekly till day 90.

Treatment groups

220 Participants
are divided into 2 treatment groups
Group A: control/Usual CareNo intervention 0 interventions
Group B: intervention armExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

the occurrence of heart failure-related hospital readmission within 30 days and within 90 days after discharge from the index hospitalization

the occurrence of heart failure-related hospital readmission within 30 days and within 90 days after discharge from the index hospitalization

Time frame
90 days

Secondary outcomes

1

1. Readmission rate of heart failure patients on guideline-directed heart failure medications

The readmission rate of heart failure patients on guideline-directed medical therapy (GDMT) will be compared to those who are not on GDMT.

Time frame
90days
2

Quality of life of the heart failure patients at 90 days

Quality of life at 90 days will be measured using the Kansas City Cardiomyopathy Questionnaire (KCCQ).

Time frame
90days
3

All-cause mortality within 30 and 90 days

. Assessing all-cause mortality will involve tracking total deaths from any reason within a population over the 90-day follow-up

Time frame
90 days
4

Caregiver burden in heart failure management

Caregiver burden will be assessed using the standard tool "Caregiver Burden Questionnaire - Heart Failure Version 3.0 (CBQ-HF)

Time frame
30 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Komfo Anokye Teaching Hospital

Lead sponsor

Source ClinicalTrials.gov
Apply now